Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
31 hedge funds and large institutions have $12.4M invested in Biolase, Inc. in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
3% less funds holding
Funds holding: 32 → 31 (-1)
16% less capital invested
Capital invested by funds: $14.8M → $12.4M (-$2.41M)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.09M |
| 2 |
State Street
Boston,
Massachusetts
|
+$392K |
| 3 |
VF
Virtu Financial
New York
|
+$163K |
| 4 |
Two Sigma Investments
New York
|
+$81.7K |
| 5 |
Goldman Sachs
New York
|
+$52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$549K |
| 2 |
BlackRock
New York
|
-$425K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$273K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$271K |
| 5 |
Millennium Management
New York
|
-$130K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
26
Scotia Capital
Toronto,
Ontario, Canada
| $7K | – | – | – |
|
|
SXL
27
Summit X LLC
Chesterfield,
Missouri
| $7K | – | – | – |
|
|
WSC
28
Wellington Shields & Co
New York
| $7K | – | – | – |
|
|
TFO
29
Tarbox Family Office
Newport Beach,
California
| $5K | – | – | – |
|
|
SWM
30
Spire Wealth Management
Mclean,
Virginia
| $3K | +$3.71K | +2 | New |
|
|
IA
31
IFP Advisors
Tampa,
Florida
| $2K | – | – | – |
|
32
1832 Asset Management
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
33
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
APA
34
American Portfolios Advisors
Holbrook,
New York
| $282 | – | – | – |
|
35
Squarepoint
New York
| – | -$15K | -7 | Closed |
|
|
WP
36
WealthSource Partners
San Luis Obispo,
California
| – | -$13K | -6 | Closed |
|
37
Jane Street
New York
| – | -$11K | -5 | Closed |
|
|
SHA
38
Seneca House Advisors
Richmond,
Virginia
| – | -$9K | -4 | Closed |
|
39
Osaic Holdings
Scottsdale,
Arizona
| – | -$3.71K | -2 | Closed |
|
|
IAIM
40
International Assets Investment Management
Orlando,
Florida
| – | -$1K | -1 | Closed |
|
BIOL Hedge Fund Activity: Q2 2021 in Review
31 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2021, worth a combined $12.4M — down 16% from $14.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BIOL and 5 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 5 added.
The largest buyer was Perkins Capital Management, adding an estimated $1.09M. The largest seller was Renaissance Technologies, cutting an estimated $549K.
- 31 institutional investors held Biolase, Inc. (BIOL) as of Q2 2021, down from 32 in Q1 2021.
- Funds reported $12.4M of Biolase, Inc. stock for Q2 2021, down 16% quarter-over-quarter.
- 5 funds opened new Biolase, Inc. positions in Q2 2021 and 6 closed out, a net change of -1 holder.
- The largest Biolase, Inc. buyer in Q2 2021 was Perkins Capital Management, an estimated $1.09M added.
- The largest Biolase, Inc. seller in Q2 2021 was Renaissance Technologies, an estimated $549K sold.
Based on aggregated 13F filings for Q2 2021.